| 0.9148 Delayed Data As of 8:00pm ET |  +0.0083 / +0.92%Today’s Change | 0.59 Today|||52-Week Range 1.78 | +29.14% Year-to-Date |
| Palatin's (PTN) to Report Q4 Earnings: What's in the Cards? Aug 16 / Zacks.com - Paid Partner Content | Palatin (PTN) Stock Sinks As Market Gains: What You Should Know Aug 13 / Zacks.com - Paid Partner Content |
| Previous close | 0.91 |
| Today’s open | 0.91 |
| Day’s range | 0.90 - 0.92 |
| Volume | 513,431 |
| Average volume (3 months) | 3,184,904 |
| Market cap | $225.2M |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -180.01% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +50.11% |
| P/E ratio | NM |
| Price/Sales | 2.99 |
| Price/Book | 6.81 |
| Today’s change | Today’s % change | |
|---|---|---|
| MNKDMannKind Corp | -0.02 | -2.14% |
| XENEXenon Pharmaceutical... | +0.03 | +0.34% |
| OCULOcular Therapeutix I... | +0.01 | +0.22% |
| PHASPhaseBio Pharmaceuti... | +0.90 | +12.03% |
| Next reporting date | September 11, 2019 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $67.1M |
| Annual profit (last year) | $24.7M |
| Net profit margin | 36.80% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Carl Spana |
COO, CFO, Secretary, Treasurer & Executive VP Stephen T. Wills |
Corporate headquarters Cranbury, New Jersey |
